Fludarabine, Cyclophosphamide and Mitoxantrone in Relapsed or Refractory Chronic Lymphocytic Leukemia and Low Grade Non-Hodgkin's Lymphoma

References

• Hiddemann, W., Rottmann, R., Wormann, B., Theil, A., Essink, M., Ottensmeier, C., et al. (1991) "Treatment of advanced chronic lymphocytic leukaemia by fludarabine: Results of a clinical study", Ann. Haematol., 63, 1–4.
   Web of Science ®Google Scholar
• Fenchel, K., Bergmann, L., Wijermans, P., Engert, A., Pralle, H., Mitrou, P.S., et al. (1995) "Clinical experience with fludarabine and its immunosuppressive effects in pre-treated chronic lymphocytic leukemias and low-grade lymphomas", Leukemia Lymphoma, 18, 485 —492.
   Google Scholar
• Johnson, S., Smith, AG., Loffler, H., Osby, E., Juliusson, G., Emmerich, B., et al. (1996) "Multi-centre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin and prednisolone (CAP) for treatment of advanced stage chronic lymphocytic leukaemia. The French Co-operative Group on CLL", Lancet, 347, 1432— 1438.
   Google Scholar
• Montserrat, E., Lopez- Lorenzo, J.L., Manso, F., Martin, A., Prieto, E., Arias-Sampedro, J., et al. (1996) "Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience", Leukemia and Lymphoma, 21, 467 — 472.
   Google Scholar
• Rai, KR., Peterson, B., Applebaum, FR., Kolitz, J., Elias, L., Shepherd, L., et al. (2000) "Fludarabine compared with chloram-bucil as primary therapy for chronic lymphocytic leukemia", N. Engl. J. Med., 343, 1750— 1757.
   Web of Science ®Google Scholar
• Keating, M., O'Brien, S., Lerner, S., Koller, C., Beran, M., Robertson, L.E., et al. (1998) "Long-term follow up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy", Blood, 92, 1165–1171.
   PubMed Web of Science ®Google Scholar
• Koel, U., Li, L., Nowak, B., Ruiz van Haperen, V., Kornhuber, B., Schwabe, D., et al. (1997) "Fludarabine and cyclophosphamide: Synergistic cytotoxicity associated with inhibition of interstrand cross-link removal", Proc. Am. Assoc. Cancer Res., 38, 2a.
   Google Scholar
• Bellosillo, B., Villamor, N., Colomer, D., Pons, G., Montserrat, E., and Gil, J. (1999) "In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia", Blood, 94, 2836–2843.
   Google Scholar
• Frewin, R., Turner, D., Tighe, M., Davies, S., Rule, S. and Johnson, S. (1999) "Combination therapy with fludarabine and cyclopho-sphamide as salvage treatment in lymphoproliferative disorders", British Journal of Haematology, 104, 612–613.
   Google Scholar
• Flinn, I.W., Byrd, J.C., Morrison, C., Jamison, J., Diehl, L.F., Murphy, T., et al. (2000) "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies", Blood, 96, 71–75.
   Google Scholar
• Hochster, H., Oken, M., Bennett, J., Winter, J.N., Gordon, L.I., Raphael, B.G., et al. (2000) "Phase 1 study of fludarabine plus cyclophosphamide in patients with previously untreated low- grade lymphoma: results and long-term follow up: a report from the Eastern Co-operative Oncology Group", Journal of Clinical Oncology, 18, 987–994.
   PubMed Web of Science ®Google Scholar
• Marotta, G., Bigazzi, C., Lenoci, M., Tozzi, M., Bocchia, M. and Lauria, F. (2000) "Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukaemia refrac-tory to conventional therapy", Haematologica, 85, 1268 — 1270.
   Google Scholar
• Hallek, M., Schmitt, B., Wilhelm, M., Busch, R., Krober, A., Fostitsch, H.P., et al. (2001) "Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic; leukaemia (CLL): results of a phase II study of the German CLL study group", British Journal of Haematology, 114, 342–348.
   PubMed Web of Science ®Google Scholar
• O'Brien, S.M., Kantarjian, H.M., Cortes, J., Beran, M., Koller, C.A., Giles, F.J., et al. (2001) "Results of the Fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia", Journal of Clinical Oncology, 19, 1414 — 1420.
   Google Scholar
• McLaughlin, P., Hagemeister, F.B., Romaguera, J.E., Sarris, A.H., Pate, O., Younes, A., et al. (1996) "Fludarabine, mitoxantrone and dexamethasone: an effective new regimen for indolent lymphoma", Journal of Clinical Oncology, 14, 1262— 1268.
   Web of Science ®Google Scholar
• Robertson, L.E., O'Brien, S., Kantarjian, H., Koller, C., Beran, M., Andreeff, M., et al. (1995) "Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia", Leukemia, 9, 943–945.
   PubMed Web of Science ®Google Scholar
• Zinzani, P.L., Magagnoli, M., Bendandi, M., Gherlinzoni, F., Orcioni, G.F., Cellini, C., et al. (2000) "Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas", Annuals of Oncology, 11, 363— 365.
   Google Scholar
• Rummel, M.J., Kafer, G., Pfreundschuh, M., Jager, E., Reinhardt, U., Mitrou, P.S., et al. (1999) "Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II study", Annals of Oncology, 10, 183 — 188.
   Google Scholar
• Gregory, S.A., Vose, J., Modiano, M., Kraemer, K., Rifkin, R., Rubin, A., et al. (2001) "Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicin or mitoxantrone-containing regimen", Leukemia and Lymphoma, 40, 315— 324.
   Google Scholar
• Santini, G., Nati, S., Spriano, M., Gallamini, A., Pierluigi, D., Congiu, A.M., et al. (2001) "Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma", Haematologica, 86, 282–286.
   Google Scholar
• Bocchia, M., Bigazzi, C., Marconcini, S., Forconi, F., Marotta, G., Algeri, R., et al. (1999) "Favourable impact of low dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treat-ment for low-grade non-Hodgkin's lymphomas", Haematologica, 84, 716–720.
   Google Scholar
• Bosch, F., Ferrer, A., Lopez-Guillermo, A., Gine, E., Bellosillo, B., Villamor, N., et al. (2002) "Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemia", British Journal of Haematology, 119, 976 — 984.
   Google Scholar
• Schmitt, B.F., Franke, A., Burkhard, O., Schlag, R., Hopfinger, G., Stauch, M., et al. (2002) "Fludarabine, Mitoxantrone and Cyclophosphamide combination therapy in relapsed chronic lym-phocytic leukemia with or without G-CSF: results of the first interim analysis of a phase III study of the German CLL Group", Blood, 100, 364b (abstract 5015).
   Google Scholar
• Mauro, F.R., Foa, R., Meloni, G., Gentile, M., Giammartini, E., Giannarelli, D., et al. (2002) "Fludarabine, ara-C novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukaemia patients", Haematologica, 87, 926–933.
   Google Scholar
• Zaja, F., Rogato, A., Russo, D., Marin, L., Silvestri, F. and Baccarani, M. (1997) "Combined therapy with fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas", European Journal of Haematology, 59, 327–328.
   Google Scholar
• Lazzarino, M., Orlandi, E., Baldanti, F., Furione, M., Pagnucco, G., Astori, C., et al. (1999) "The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclopho-sphamide and dexamethasone in patients with lymphoproliferative disorders", British Journal of Haematology, 107, 877–882.
   Google Scholar
• Lossos, IS., Paltiel, O. and Polliack, A. (1999) "Salvage chemotherapy using a combination of fludarabine and cyclopho-sphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas", Leukemia Lymphoma, 33, 155–160.
   Google Scholar
• Saso, R., Kulkarni, S., Mitchell, P., Treleaven, J., Swansbury, G.J., Mehta, J., et al. (2000) "Secondary myelodysplastic syndrome/ acute myeloid leukaemia following mitoxantrone based therapy for breast carcinoma", British Journal of Cancer, 83, 91–94.
   Google Scholar
• Pedersen-Bjergaard, J., Andersen, M.K. and Johansson, B. (1998) "Balanced chromosome aberrations in leukemias following che-motherapy with DNA-topoisomerase II inhibitors", Journal of Clinical Oncology, 16, 1897 — 1898.
   Google Scholar
• Morrison, V.A., Rai, KR., Peterson, B.L., Kolitz, J.E., Elias, L., Appelbaum, FR., et al. (2002) "Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011", The Journal of Clinical Oncology, 20, 3878–3884.
   Google Scholar
• Hiddemann, W., Dreyling, M. and Unterhalt, M. (2003) "Ritux-imab plus chemotherapy in follicular and mantle cell lymphomas", Seminars In Oncology, 30\(suppl. 2), 16–20.
   PubMed Web of Science ®Google Scholar